BWLCX
Price
$22.93
Change
+$0.15 (+0.66%)
Updated
Jul 3 closing price
Net Assets
227.27M
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

BWLCX vs VVIAX

Header iconBWLCX vs VVIAX Comparison
Open Charts BWLCX vs VVIAXBanner chart's image
American Beacon Man Lg Cp Value C
Price$22.93
Change+$0.15 (+0.66%)
VolumeN/A
Net Assets227.27M
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
BWLCX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BWLCX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BWLCX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. BWLCX (227M). VVIAX pays higher dividends than BWLCX: VVIAX (2.18) vs BWLCX (0.00). BWLCX was incepted earlier than VVIAX: BWLCX (13 years) vs VVIAX (25 years). BWLCX (1.94) is less costly to investors than VVIAX (0.05). BWLCX is a more actively managed with annual turnover of: 64.00 vs. VVIAX (9.00). BWLCX has a lower initial minimum investment than VVIAX: BWLCX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. BWLCX (-2.09). VVIAX return over 5 years is better than : 80.13 vs. BWLCX (18.25).
BWLCXVVIAXBWLCX / VVIAX
Total Expense Ratio1.940.053,880%
Annual Report Gross Expense Ratio1.940.053,880%
Fund Existence13 years25 years-
Gain YTD7.4516.198120%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets227M189B0%
Annual Yield % from dividends0.002.18-
Returns for 1 year-2.0912.03-17%
Returns for 3 years5.9535.1717%
Returns for 5 years18.2580.1323%
Returns for 10 years4.37115.674%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.